Bioscience Today

13/01/2026

People with signs of damage to their heart during middle age are more likely to develop dementia in later life, according to research funded by the British Heart Foundation https://www.biosciencetoday.co.uk/poorer-heart-health-in-middle-age-linked-to-increased-dementia-risk/

People with signs of damage to their heart during middle age are more likely to develop dementia in later life, according to research funded by the British Heart Foundation and published in the European Heart Journal.1 The study, led by scientists at University College London, found middle-aged peop...

13/01/2026

Reference standards improve AAV production. https://www.biosciencetoday.co.uk/reference-standards-improve-aav-production/

Amsbio announces a new range of well characterized Adeno-Associated Virus (AAV) reference standards that enable researchers to significantly improve their AAV production processes. Adeno-associated virus can be engineered to transport DNA of interest to target cells, without any viral genes – maki...

12/01/2026

In a clinical trial led by Stanford Medicine researchers and international collaborators, 27 out of 32 participants had regained the ability to read a year after receiving the device https://www.biosciencetoday.co.uk/eye-prosthesis-restores-sight/

A tiny wireless chip implanted in the back of the eye, together with a pair of high-tech glasses, have partially restored vision to people with an advanced form of age-related macular degeneration. In a clinical trial led by Stanford Medicine researchers and international collaborators, 27 out of 32...

11/01/2026

As biotech and AI converge, arbitration is emerging as the preferred forum for complex intellectual property disputes. Bernhard Maier, Browne Jacobson LLP, explores how this trajectory could affect life sciences businesses https://www.biosciencetoday.co.uk/arbitrating-innovation-resolving-ip-disputes-in-life-sciences/

As biotech and AI converge, arbitration is emerging as the preferred forum for complex intellectual property disputes – particularly when the underlying science defies straightforward explanation or analysis. In this exclusive feature, Bernhard Maier, partner and head of arbitration at UK and Irel...

10/01/2026

A new clinical study has found that at-home brain stimulation therapy helped 75% of patients stay depression-free over six months, solving a major gap in mental health care https://www.biosciencetoday.co.uk/at-home-brain-stimulation-prevents-major-depression-relapse/

Up to 85% of people with depression experience relapse during treatment. However, a new clinical study has found that at-home brain stimulation therapy helped 75% of patients stay depression-free over six months, solving a major gap in mental health care. The international PSYLECT study – publishe...

09/01/2026

New data indicates a growing “scientific content crisis” that is limiting the accuracy and adoption of AI in R&D https://www.biosciencetoday.co.uk/one-in-4-life-sciences-professionals-dont-know-what-data-their-ai-models-use/

Experts from companies including AstraZeneca, Bayer, Novartis, and Vertex shared insights into AI agents, accelerating clinical trials and skills gaps, at a recent US conference. New data indicates a growing “scientific content crisis” that is limiting the accuracy and adoption of AI in R&D. The...

08/01/2026

Université de Genève scientists have shed new light on how cell division disorders lead to certain cancers https://www.biosciencetoday.co.uk/how-chromosomes-separate-accurately/

UNIGE scientists have shed new light on how cell division disorders lead to certain cancers. Cell division is a process of remarkable precision: during each cycle, the genetic material must be evenly distributed between the two daughter cells. To achieve this, duplicated chromosomes, known as sister...

07/01/2026

A new way to treat asthma symptoms and even repair previously irreversible lung damage could be on the horizon, following discovery of a potential new therapeutic target by scientists at the University of Aberdeen https://www.biosciencetoday.co.uk/potential-new-therapeutic-target-for-asthma-discovered/

A new way to treat asthma symptoms and even repair previously irreversible lung damage could be on the horizon, following discovery of a potential new therapeutic target by scientists at the University of Aberdeen. the inflammation of lung tissue using steroid inhalers. However, four people die ever...

06/01/2026

Researchers at the University of Bath have developed a molecule that prevents the clumping and build-up of a protein linked to Parkinson’s disease and related dementias https://www.biosciencetoday.co.uk/scientists-design-peptide-switch-that-keeps-parkinsons-protein-in-its-healthy-form/

Researchers at the University of Bath, in collaboration with the Universities of Oxford and Bristol, have developed a molecule that prevents the clumping and build-up of a protein linked to Parkinson’s disease and related dementias. The team has successfully demonstrated it works in an animal mode...

05/01/2026

Scientists at UNIGE and HUG have created artificial immune cells capable of recognising and destroying glioblastoma cells https://www.biosciencetoday.co.uk/customised-cells-fight-brain-cancer/

Scientists at UNIGE and HUG have created artificial immune cells capable of recognising and destroying glioblastoma cells. With a five-year survival rate of less than 5%, glioblastoma is one of the most aggressive types of brain cancer. Until now, all available treatments, including immunotherapy .....

04/01/2026

Techbio startup Scripta Therapeutics has emerged from stealth by announcing a $12 million seed round to upend conventional approaches to drug discovery https://www.biosciencetoday.co.uk/scripta-therapeutics-aims-to-flip-the-script-on-disease-modifying-drugs/

03/01/2026

The discovery of a new mechanism of resistance to common antibiotics could pave the way for improved treatments for harmful bacterial infections, a study suggests https://www.biosciencetoday.co.uk/new-drug-target-identified-in-fight-against-resistant-infections/

The discovery of a new mechanism of resistance to common antibiotics could pave the way for improved treatments for harmful bacterial infections, a study suggests. Targeting this defence mechanism could aid efforts to combat antimicrobial resistance (AMR), one of the world’s most urgent health cha...